Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,853 | -11,982 | -7,058 |
| Other Working Capital | 371 | -640 | 147 |
| Other Operating Activity | 1,921 | 8,090 | 1,307 |
| Operating Cash Flow | $-5,561 | $-4,532 | $-5,605 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 2,148 | N/A |
| Common Stock Issued | 3,609 | 7,704 | 2,904 |
| Other Financing Activity | 182 | -1,068 | 242 |
| Financing Cash Flow | $3,791 | $8,784 | $3,146 |
| Beginning Cash Position | 4,603 | 351 | 2,810 |
| End Cash Position | 2,833 | 4,603 | 351 |
| Net Cash Flow | $-1,770 | $4,252 | $-2,459 |
| Free Cash Flow | |||
| Operating Cash Flow | -5,561 | -4,532 | -5,605 |
| Free Cash Flow | -5,561 | -4,532 | -5,605 |